|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004153,
umls-concept:C0008976,
umls-concept:C0010054,
umls-concept:C0011847,
umls-concept:C0011860,
umls-concept:C0030705,
umls-concept:C0031809,
umls-concept:C0289313,
umls-concept:C0332307,
umls-concept:C0449258,
umls-concept:C1280500,
umls-concept:C1708528,
umls-concept:C1880008,
umls-concept:C1956346
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-3-16
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Rosiglitazone has several properties that may affect progression of atherosclerosis. The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History (APPROACH) study was undertaken to determine the effect of the thiazolidinedione rosiglitazone on coronary atherosclerosis as assessed by intravascular ultrasound compared with the sulfonylurea glipizide.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
pubmed-author:APPROACH Study Group,
pubmed-author:CannonChristopher PCP,
pubmed-author:FitzgeraldPeter JPJ,
pubmed-author:García-GarcíaHéctor MHM,
pubmed-author:GersteinHertzel CHC,
pubmed-author:HuangChunC,
pubmed-author:KolatkarNikheel SNS,
pubmed-author:KravitzBarbara GBG,
pubmed-author:MillerDiane MDM,
pubmed-author:NestoRichard WRW,
pubmed-author:RatnerRobert ERE,
pubmed-author:SerruysPatrick WPW,
pubmed-author:van EsGerrit-AnneGA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
16
|
|
pubmed:volume |
121
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1176-87
|
|
pubmed:meshHeading |
pubmed-meshheading:20194881-Adult,
pubmed-meshheading:20194881-Aged,
pubmed-meshheading:20194881-Aged, 80 and over,
pubmed-meshheading:20194881-Coronary Artery Disease,
pubmed-meshheading:20194881-Diabetes Mellitus, Type 2,
pubmed-meshheading:20194881-Disease Progression,
pubmed-meshheading:20194881-Double-Blind Method,
pubmed-meshheading:20194881-Endpoint Determination,
pubmed-meshheading:20194881-Female,
pubmed-meshheading:20194881-Hemoglobin A, Glycosylated,
pubmed-meshheading:20194881-Humans,
pubmed-meshheading:20194881-Hypoglycemic Agents,
pubmed-meshheading:20194881-Male,
pubmed-meshheading:20194881-Middle Aged,
pubmed-meshheading:20194881-Thiazolidinediones,
pubmed-meshheading:20194881-Ultrasonography, Interventional
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: the assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial.
|
|
pubmed:affiliation |
McMaster University and Hamilton Health Sciences, Department of Medicine, Hamilton, Ontario L8N 3Z5, Canada. gerstein@mcmaster.ca
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
